Bacil Pharma Limited (BOM:524516)
India · Delayed Price · Currency is INR 38.38
+0.02 (0.05%)
At close: Jul 10, 2026
Bacil Pharma Market Cap
Bacil Pharma has a market cap or net worth of 550.87 million as of July 10, 2026. Its market cap has increased by 115.00% in one year.
Market Cap
550.87M
Enterprise Value
545.18M
Revenue
n/a
Ranking
n/a
PE Ratio
34.58
Stock Price
38.38
Market Cap Chart
Since April 23, 2007, Bacil Pharma's market cap has increased from 21.80M to 550.87M, an increase of 2,426.79%. That is a compound annual growth rate of 18.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 550.87M | 7.69% |
| Dec 31, 2025 | 511.54M | 59.83% |
| Dec 31, 2024 | 320.06M | 751.72% |
| Dec 29, 2023 | 37.58M | -32.13% |
| Dec 23, 2022 | 55.37M | 31.47% |
| Dec 31, 2021 | 42.11M | 51.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Resonance Specialties | 1.56B |
| Auro Laboratories | 1.55B |
| Kimia Biosciences | 1.43B |
| Smruthi Organics | 1.40B |
| Tyche Industries | 1.25B |
| Krebs Biochemicals & Industries | 1.18B |
| Vasundhara Rasayans | 553.01M |
| Crestchem | 382.95M |